{
    "clinical_study": {
        "@rank": "31655", 
        "arm_group": [
            {
                "arm_group_label": "NM Regional Honey", 
                "arm_group_type": "Experimental", 
                "description": "15 ml of NM Honey applied directly to wound"
            }, 
            {
                "arm_group_label": "Bactrim DS", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard of Care Oral Antibiotic"
            }
        ], 
        "brief_summary": {
            "textblock": "In a time of emerging bacteria that are resistant to antibiotics, honey offers an\n      alternative that has potential to reduce the heavy reliance on pharmaceutical antibiotics.\n      We will be evaluating the effectiveness of a locally produced New Mexico Honey against the\n      standard of care Bactrim antibiotic on Community Acquired MRSA."
        }, 
        "brief_title": "New Mexico Honey Wound Treatment Research Study", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Community-acquired MRSA Infection", 
        "detailed_description": {
            "textblock": "Locally grown New Mexico Honey will be utilized on abscess wounds of the trunk and\n      extremities vs routine (Bactrim) antibiotic care to determine if NM Honey is effective\n      treatment for Community Acquired MRSA 6 cm abscesses."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients 16 years of age or older\n\n          -  Abscess less than or equal to 6 cm in diameter on the extremity or trunk requiring\n             incision and drainage\n\n          -  Patient willing to try honey prepared dressing\n\n          -  Patient able to return to office each day for 7 days for evaluation\n\n        Exclusion Criteria:\n\n          -  Under the age of 16\n\n          -  Abscess of face, scalp or genitals\n\n          -  Diagnosed as a diabetic\n\n          -  Allergic to bee pollen, honey or sulfa antibiotics\n\n          -  Diagnosed with peripheral vascular disease\n\n          -  Patient acknowledgement of current drug or alcohol abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01748318", 
            "org_study_id": "IND 115653"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "NM Regional Honey", 
                    "Bactrim DS"
                ], 
                "description": "Apply 15 ml of NM Honey to CA-MRSA Abscess compare to standard antibiotic treatment", 
                "intervention_name": "New Mexico Honey", 
                "intervention_type": "Drug", 
                "other_name": "Local New Mexico Honey"
            }, 
            {
                "arm_group_label": [
                    "NM Regional Honey", 
                    "Bactrim DS"
                ], 
                "description": "Bactrim DS", 
                "intervention_name": "Bactrim DS", 
                "intervention_type": "Drug", 
                "other_name": "sulfamethoxazle-trimethroprim DS"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Trimethoprim-Sulfamethoxazole Combination"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Community acquired MRSA", 
            "New Mexico Honey"
        ], 
        "lastchanged_date": "December 10, 2012", 
        "location": {
            "contact": {
                "last_name": "R Stephen Rankin, MD", 
                "phone": "505-324-1000"
            }, 
            "facility": {
                "address": {
                    "city": "Farmington", 
                    "country": "United States", 
                    "state": "New Mexico", 
                    "zip": "87401"
                }, 
                "name": "Pinon Family Practice"
            }, 
            "investigator": {
                "last_name": "R Stephen Rankin, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "New Mexico Honey Wound Treatment Research Study", 
        "overall_contact": {
            "email": "rstephen_rankin@msn.com", 
            "last_name": "R Stephen Rankin, MD", 
            "phone": "505 324 1000"
        }, 
        "overall_contact_backup": {
            "email": "jpope10@msn.com", 
            "last_name": "Joseph Pope, MD", 
            "phone": "505 324 1000"
        }, 
        "overall_official": {
            "last_name": "R Stephen Rankin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Increase in size will determine failure; Decrease in size will determine success", 
            "measure": "Size of lesion at day 7", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01748318"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rankin, R. Stephen, M.D.", 
            "investigator_full_name": "R. Stephen Rankin, M.D.", 
            "investigator_title": "Primary Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Rankin, R. Stephen, M.D.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "R. Stephen Rankin, M.D.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}